CIDRAP newsletters options
A retrospective study of COVID-19 patients in New York City hospitals found that treatment with the antimalaria drug hydroxychloroquine, the antibiotic azithromycin, or both was not significantly associated with differences in in-hospital mortality compared with patients who received neither drug.
The WHO also warns that COVID-19 disruptions could hurt the battle against HIV.
73% of patients had respiratory symptoms, while 23% had failure of at least two organ systems.
Some 5,000 COVID-19 deaths in New York City might not have been counted, a new report says.
A phase 2 trial has shown that a 2-week course of triple antiviral therapy with interferon beta-1b plus lopinavir-ritonavir and ribavirin is safe and better at shortening COVID-19 viral shedding than lopinavir-ritonavir alone in patients with mild to moderate illness if started within 7 days of symptom onset.
A low-intensity, multifaceted stewardship intervention implemented at nursing homes was associated with improved antibiotic prescribing for urinary tract infections (UTIs), US researchers reported today in JAMA Internal Medicine.
Also, New York officials said 3 children have died from what might be a recently identified inflammatory complication.
In a poll, almost two thirds of Americans say they fear it's too soon to reopen the economy.
The drug was not tied to lower rates of intubation or death in COVID-19 patients.
The WHO voices concern over increased domestic violence in nations under stay-at-home orders.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Originally published by CIDRAP News May 7
The Infectious Diseases Society of America (IDSA) and five other medical organizations are urging changes to a national set of care measures for sepsis patients, with the aim of reducing unnecessary antibiotic use in patients who may not need them.
Afghanistan, Pakistan, Chad, and Niger have reported new polio cases—14 in all—according to this week's Global Polio Eradication Initiative (GPEI) update.
A study yesterday in JAMA Network Open is the first to demonstrate that SARS-CoV-2, the virus that causes COVID-19, is detectable in the semen of recovered and actively infected men, but it does not prove that the virus can be sexually transmitted.
Several patients had deep vein thrombosis, suggesting the virus may cause abnormal blood clotting.
Continued spread in Africa could prolong the outbreak and overwhelm hospitals.
Also, new models predict a spike in cases in late May after states reopen from lockdowns.
A systematic review published yesterday in The Lancet Infectious Diseases underscores the importance of precautions to minimize the risk of transmitting Ebola via breastfeeding.
COVID-19 "has created the greatest financial crisis in history for hospitals and health systems."
Resources may be especially taxed in some US cities with vulnerable populations.
